BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 34737799)

  • 1. Effect of NFATc2- and Sp1-mediated TNFalpha Regulation on the Proliferation and Migration Behavior of Pancreatic Cancer Cells.
    Malsy M; Graf B; Bruendl E; Maier-Stocker C; Bundscherer A
    Cancer Genomics Proteomics; 2023 Dec; 20(6suppl):706-711. PubMed ID: 38035702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC00857 promotes the proliferation of pancreatic cancer via MET, STAT3, and CREB.
    Song Y; Liang Y; Zou Q; Zeng S; Lin H; Liu M; Liu X; Du J; Chen G; Zou L; Su W; Niu F
    J Gastrointest Oncol; 2021 Dec; 12(6):2622-2630. PubMed ID: 35070392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone Marrow Stromal Antigen 2 is a Potential Unfavorable Prognostic Factor for High-Grade Glioma.
    Shi H; Luo K; Huang W
    Onco Targets Ther; 2020; 13():8723-8734. PubMed ID: 32943880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of cFos by the Transcription Factors NFATc2 and Sp1 in Pancreatic Cancer Cells.
    Malsy M; Graf B; Bruendl E; Maier-Stocker C; Bundscherer A
    Anticancer Res; 2023 Nov; 43(11):4897-4904. PubMed ID: 37909980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti‑silencing function 1B promotes the progression of pancreatic cancer by activating c‑Myc.
    Zhang M; Zhang L; Zhou M; Wang E; Meng B; Li Q; Wang X; Wang Y; Li Q
    Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36416310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-Induced Bone Marrow Stromal Antigen 2 (BST2) Is A Functional Tumor-Initiating Cell Marker In Triple-Negative Breast Cancer.
    Souto EP; Gong P; Landua JD; Srinivasan RR; Ganesan A; Dobrolecki LE; Purdy SC; Ford HL; Lewis MT
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BST2 regulated by the transcription factor STAT1 can promote metastasis, invasion and proliferation of oral squamous cell carcinoma via the AKT/ERK1/2 signaling pathway.
    Shan F; Shen S; Wang X; Chen G
    Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36929425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CpG-binding protein CFP1 promotes ovarian cancer cell proliferation by regulating BST2 transcription.
    Yang LQ; Hu HY; Han Y; Tang ZY; Gao J; Zhou QY; Liu YX; Chen HS; Xu TN; Ao L; Xu Y; Che X; Jiang YB; Xu CW; Zhang XC; Jiang YX; Heger M; Wang XM; Cheng SQ; Pan WW
    Cancer Gene Ther; 2022 Dec; 29(12):1895-1907. PubMed ID: 35864225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Reveals That TAM2-Driven Genes Affect Immunotherapeutic Response and Prognosis in Pancreatic Cancer.
    Du Y; Dong S; Jiang W; Li M; Li W; Li X; Zhou W
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity protein 1/microRNA-92b forms a feedback loop promoting the migration and invasion of head and neck squamous cell carcinoma.
    Pang P; Fang H; Wu H; Wang S; Liu M; Jin S; Qi Z; Li Z; Liu F; Sun C
    Bioengineered; 2021 Dec; 12(2):11397-11409. PubMed ID: 34905435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KiSS‑1‑mediated suppression of the invasive ability of human pancreatic carcinoma cells is not dependent on the level of KiSS‑1 receptor GPR54.
    Wang CH; Qiao C; Wang RC; Zhou WP
    Mol Med Rep; 2016 Jan; 13(1):123-9. PubMed ID: 26572251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR‑539 suppresses the proliferation, migration, invasion and epithelial mesenchymal transition of pancreatic cancer cells through targeting SP1.
    Xue L; Shen Y; Zhai Z; Zheng S
    Int J Mol Med; 2020 Jun; 45(6):1771-1782. PubMed ID: 32236568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
    Cai D; Cao J; Li Z; Zheng X; Yao Y; Li W; Yuan Z
    BMC Cancer; 2009 Apr; 9():102. PubMed ID: 19338666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-573 suppresses pancreatic cancer cell proliferation, migration, and invasion through targeting TSPAN1.
    Wang L; Gao P; Yuan P; Zhou P; Fan H; Lin X; Yuan X; Zhu M; Fan X; Lu Y; Wang Z
    Strahlenther Onkol; 2021 May; 197(5):438-448. PubMed ID: 33320287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review).
    Yu H; Bian Q; Wang X; Wang X; Lai L; Wu Z; Zhao Z; Ban B
    Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38240088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity protein 1-activated bone marrow stromal cell antigen 2 accelerates pancreatic cancer cell proliferation and migration.
    Lei C; Hou Y; Chen J
    Exp Ther Med; 2021 Dec; 22(6):1459. PubMed ID: 34737799
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.